Vital Signs - The Analyst's Perspective - June 2015 Issue

Vital Signs - The Analyst's Perspective - June 2015 Issue

RELEASE DATE
10-Jul-2015
REGION
Asia Pacific
Research Code: 9A35-00-3A-00-00
SKU: HC02615-AP-MR_16737

$450.00

Special Price $337.50 save 25 %

In stock
SKU
HC02615-AP-MR_16737

$450.00

$337.50 save 25 %

DownloadLink

Pay by invoice

ENQUIRE NOW

Description

This issue of Vital Signs, released in July 2015, discusses Affmetrix's acquisition of Eureka Genomics, OPKO Health's acquisition of Bio-Reference Laboratories, CVS Health's acquisition of Target's in-store pharmacies and clinics, and Thermo Fisher Scientific's acquisition of Alfa Aesar.

Table of Contents

This month's issue

Related Research
The research service presents an overview and analysis of the China contract research organisation (CRO) market. It provides revenue forecasts by phase and therapeutic type and discusses the major issues and challenges, unmet needs, and emerging trends in the market. The study also covers the complete life cycle of the CRO industry, starting from preclinical to late phase clinical trials. It provides detailed information about support services such as central laboratory services, bioanalytics, and data management, and analyses market engineering measurements and research and development trends.
More Information
No Index No
Podcast No
Author Christi Bird
Industries Healthcare
WIP Number 9A35-00-3A-00-00
Is Prebook No